Paul Rodgers

Chelmsford-based e2v biosensors, a subsidiary of e2v technologies plc, has appointed Dr Paul Rodgers to the position of chief executive, to lead the company through the commercialisation of its novel biosensor platform technology.

Chelmsford-based e2v biosensors, a subsidiary of e2v technologies plc, has appointed Dr Paul Rodgers to the position of chief executive, to lead the company through the commercialisation of its novel biosensor platform technology.

Dr Rodgers is an entrepreneur with 25 years' experience in the life sciences industry and has founded 10 biotechnology companies. He has extensive experience in fund-raising, management of research and development, strategic business development, and licensing and protection of intellectual property.

He has worked in the pharmaceuticals, food, fine chemicals and agriculture sectors.

Dr Rodgers, who is also chief executive of Ithaka Life Sciences, said: “I am thrilled to be leading e2v's biosensors team. I intend to focus on early applications for this new platform and develop collaborations to bring the technology to market.


You may also want to watch:


“We have demonstrated the technology and achieved outstanding results, this platform has a great future and will find applications throughout both medical diagnostics and life sciences.”

Most Read

Become a Supporter

This newspaper has been a central part of community life for many years. Our industry faces testing times, which is why we're asking for your support. Every contribution will help us continue to produce local journalism that makes a measurable difference to our community.

Become a Supporter
Comments powered by Disqus